Nano antibody of clostridium difficile glutamate dehydrogenase, and encoding sequence, screening method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NINGXIA MEDICAL UNIV
- Publication Date
- 2019-02-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of immunology, and in particular relates to a nanobody of Clostridium difficile glutamic acid dehydrogenase, its coding sequence, its screening method and application. Background technique
[0002] A heavy-chain antibody naturally deficient in light chains is present in the peripheral blood of camels, which contains only a heavy-chain variable domain and two conventional CH2 and CH3 domains. The single-domain antibody obtained by cloning the variable region of the heavy chain by PCR technology is called VHH antibody (variable domain of heavy-chain antibody, VHH). nm, 4nm long, so it is also called nanobody (nanobody, Nb). Nanobody is the smallest antibody with complete antigen-binding activity known so far. Due to its small size, it has strong antigen-antibody binding ability and can be highly expressed in prokaryotic and eukaryotic cells. In addition, it also has a stable structure and high hydrophilicity...